Also Known As:
- Bile Duct Cancer
- Cancer of the Bile Duct
Why is RareCan interested in Cholangiocarcinoma?
RareCan is working to accelerate research into Cholangiocarcinoma by making it easier for researchers to connect with people who have this and other rare forms of cancer. You can help us do this by becoming a RareCan member and sharing information with us about your diagnosis. We will then get in touch with you about any research opportunities that might be suitable for you.
RARECAN ALREADY HAS
What is Cholangiocarcinoma?
Cholangiocarcinoma is a type of rare cancer that forms in the bile ducts. It is an adenocarcinoma, which is a type of cancerous tumour that can occur in several parts of the body.
How rare is Cholangiocarcinoma?
Cholangiocarcinoma or Bile Duct Cancer has around 1,000 new cases per year in the UK.
Who does Cholangiocarcinoma affect?
Cholangiocarcinoma can occur at any age but usually affects people over the age of 50.
Cholangiocarcinoma is a type of adenocarcinoma. As well as in the bile ducts, adenocarcinomas can occur in several other parts of the body.
If you have Cholangiocarcinoma/Bile Duct Cancer and are looking for support, we recommend the following websites:
Opportunities for Members with Cholangiocarcinoma
The RareCan BioResource
Donating your samples for medical research
Joining RareCan gives you the ability to donate your tissue samples to the BioResource for medical research. Please note that signing up to RareCan does not commit you to donating tissue and you can cancel your membership at any time. If you have Cholangiocarcinoma (Cancer of the Bile Duct) and would like to find out more, please click the button below.
I have a cancer diagnosis
If you have a cancer diagnosis or you are the parent of a child with a cancer diagnosis, please start here.
I'm a supporter
If you’re a friend or family member of someone with cancer, a nurse, an oncologist, an activist, a fundraiser or you’d simply like to help, please start here.
I'm a researcher
If you are interested in setting up a research project or clinical trial aimed at improving the care people affected by rare cancer receive please start here.